We invest in promising and scalable start-ups in:

  • Life Sciences (biotech, pharmaceuticals, diagnostics)
  • Digital Health
  • Medical Devices
  • Animal Health

We do not invest in healthcare providers or consultancy firms.

TRL stands for ‘Technology Readiness Level’ and indicates a product or technology’s current phase of development. There are several ways to define TRL, but we use the EU system. Click here to take a look at our detailed TRL descriptions or download the document.


Yes, as long as they satisfy our criteria and terms & conditions.

The Utrecht Holdings team manages the Utrecht Health Seed Fund (UHSF). Utrecht Holdings has been investing in University Medical Center Utrecht and University of Utrecht spin-offs since 1998 and it also has been managing their intellectual property (IP) portfolios. With the Utrecht Health Seed Fund Utrecht Holdings will be expanding its investment activities to opportunities throughout the province of Utrecht.

Please visit the Utrecht Holdings website for more information.

No, the UHSF only approves and funds companies satisfying the investment committee’s terms & conditions and investment focus.

The main criteria for eligibility are as follows:

The company seeking investment is a promising start-up that:

  • is developing a product or service in the field of Life Sciences & Health,
  • is in an early stage of development (TRL 2–7), and
  • has registered offices in the province of Utrecht.

Our portal lists the information and documents we require. Our Investment Terms & Conditions are also available for download: https://uhsf.nl/en/investment-terms-conditions/

When we use the term ‘co-investor’ or ‘co-financier’, we mean a third party who invests in a company by means of a convertible loan, equity, or other forms of corporate finance.

Although research grants are extremely important to companies in their early stages, we do not view grant providers as constituting a ‘co-financier’.

No, the UHSF only invests in BVs (Dutch privately held corporations).